We have located links that may give you full text access.
Examining the Psychometric Properties of the Expanded Levenson Self-Report Psychopathy Scale in Community and University Samples.
Assessment 2022 August 3
The aim of the current study was to further examine the psychometric properties of the Expanded Levenson Self-Report Psychopathy Scale (E-LSRP; Christian & Sellbom, 2016). Specifically, its reliability, internal structure, and convergent and discriminant validity were evaluated using university ( N = 367) and community samples ( N = 205) from Aotearoa New Zealand. The results provided support for the reliability and validity of the E-LSRP in both samples. More specifically, the internal consistency estimates of the E-LSRP were above the meaningful threshold, indicating good reliability. Furthermore, using confirmatory factor analysis, the hypothesized three-factor structure was supported and conceptually consistent with Cooke and Michie's (2001) Psychopathy Checklist-Revised (PCL-R) three-factor model. Lastly, the results generally provided support for the convergent and discriminant validity of the E-LSRP subscales; the E-LSRP Egocentricity was associated with criteria relevant to interpersonal impairment, the Callous scale with criteria relevant to the affective psychopathy domain, and the Antisocial scale with criteria representing behavioral dysfunction. Overall, the E-LSRP is a promising tool for assessing psychopathy in nonincarcerated populations.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app